MEN1 in pancreatic endocrine tumors: Analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases

Endocrine-Related Cancer

Volumn 17, Issue 3, 2010, Pages 771-783

  Corbo, Vincenzo ^a   Dalai, Irene ^a   Scardoni, Maria ^a   Barbi, Stefano ^a   Beghelli, Stefania ^a   Bersani, Samantha ^a   Albarello, Luca ^b   Doglioni, Claudio ^b   Schott, Christina ^c   Capelli, Paola ^a   Chilosi, Marco ^a   Boninsegna, Letizia ^a   Becker, Karl Friedrich ^c   Falconi, Massimo ^a   Scarpa, Aldo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FANCONI ANEMIA GROUP D2 PROTEIN; GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHIONINE; SMAD3 PROTEIN; TRANSCRIPTION FACTOR JUND; TRANSCRIPTION FACTOR SIN3A;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MEN 1 GENE; MISSENSE MUTATION; MULTIPLE ENDOCRINE NEOPLASIA; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; PANCREAS ISLET CELL TUMOR; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SOMATIC MUTATION; SPLICING DEFECT; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CELL DIFFERENTIATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PANCREATIC NEOPLASMS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77956354202     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-10-0028     Document Type: Article

References (43)

1. Achille A, Biasi MO, Zamboni G, Bogina G, Magalini AR, Pederzoli P, Perucho M & Scarpa A 1996 Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Research 56 3808-3813. (Pubitemid 26272033)
2. Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM et al. 1999 Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96 143-152.
3. Agarwal SK, Novotny EA, Crabtree JS, Weitzman JB, Yaniv M, Burns AL, Chandrasekharappa SC, Collins FS, Spiegel AM & Marx SJ 2003 Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter. PNAS 100 10770-10775.
4. Arnold CN, Sosnowski A, Schmitt-Graff A, Arnold R & Blum HE 2007 Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro-enteropancreatic system. International Journal of Cancer 120 2157-2164.
5. Balakrishnan A, Bleeker FE, Lamba S, Rodolfo M, Daniotti M, Scarpa A, van Tilborg AA, Leenstra S, Zanon C & Bardelli A 2007 Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. Cancer Research 67 3545-3550.
6. Bazzi W, Renon M, Vercherat C, Hamze Z, Lacheretz-Bernigaud A, Wang H, Blanc M, Roche C, Calender A, Chayvialle JA et al. 2008 MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells. Gastroenterology 135 1698-1709 e1692.
7. Becker KF, Schott C, Hipp S, Metzger V, Porschewski P, Beck R, Nahrig J, Becker I & Hofler H 2007 Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. Journal of Pathology 211 370-378.
8. Bergman L, Boothroyd C, Palmer J, Grimmond S, Walters M, Teh B, Shepherd J, Hartley L & Hayward N 2000 Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours. British Journal of Cancer 83 1003-1008.
9. Cao Y, Liu R, Jiang X, Lu J, Jiang J, Zhang C, Li X & Ning G 2009 Nuclear-cytoplasmic shuttling of menin regulates nuclear translocation of β-catenin. Molecular and Cellular Biology 29 5477-5487.
10. Capelli P, Martignoni G, Pedica F, Falconi M, Antonello D, Malpeli G & Scarpa A 2009 Endocrine neoplasms of the pancreas: pathologic and genetic features. Archives of Pathology & Laboratory Medicine 133 350-364.
11. Capurso G, Lattimore S, Crnogorac-Jurcevic T, Panzuto F, Milione M, Bhakta V, Campanini N, Swift SM, Bordi C, Delle Fave G et al. 2006 Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets. Endocrine-Related Cancer 13 541-558.
12. Cavallari I, D'Agostino DM, Ferro T, Rosato A, Barzon L, Pasquali C, Fogar P, Theodoropoulou M, Esposito G, Boscaro M et al. 2003 In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. Journal of Clinical Endocrinology and Metabolism 88 3893-3901.
13. Cavallari I, Silic-Benussi M, Rende F, Martines A, Fogar P, Basso D, Vella MD, Pedrazzoli S, Herman JG, Chieco-Bianchi L et al. 2009 Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma. Genes, Chromosomes and Cancer 48 383-396.
14. Cecconi D, Donadelli M, Rinalducci S, Zolla L, Scupoli MT, Scarpa A, Palmieri M & Righetti PG 2007 Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. Proteomics 7 1644-1653.
15. Chakrabarti R, Srivatsan ES, Wood TF, Eubanks PJ, Ebrahimi SA, Gatti RA, Passaro E Jr & Sawicki MP 1998 Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13. Genes, Chromosomes and Cancer 22 130-137.
16. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA et al. 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276 404-407.
17. De Carlo E, Pilon C, Zatelli MC, degli Uberti EC & Fallo F 2008 Isolated R171Q amino acid change in MEN1 gene: polymorphism or mutation? Clinical Endocrinology 69 511.
18. Eubanks PJ, Sawicki MP, Samara GJ, Gatti R, Nakamura Y, Tsao D, Johnson C, Hurwitz M, Wan YJ & Passaro E Jr 1994 Putative tumor-suppressor gene on chromosome 11 is important in sporadic endocrine tumor formation. American Journal of Surgery 167 180-185.
19. Gortz B, Roth J, Krahenmann A, de Krijger RR, Muletta-Feurer S, Rutimann K, Saremaslani P, Speel EJ, Heitz PU & Komminoth P 1999 Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. American Journal of Pathology 154 429-436.
20. Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS & Chandrasekharappa SC 1998 Menin, the product of the MEN1 gene, is a nuclear protein. PNAS 95 1630-1634.
21. Heppner C, Bilimoria KY, Agarwal SK, Kester M, Whitty LJ, Guru SC, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ et al. 2001 The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation. Oncogene 20 4917-4925.
22. Jin S, Mao H, Schnepp RW, Sykes SM, Silva AC, D'Andrea AD & Hua X 2003 Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Research 63 4204-4210. (Pubitemid 36917947)
23. Jonkers YM, Claessen SM, Feuth T, van Kessel AG, Ramaekers FC, Veltman JA & Speel EJ 2006 Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis. Journal of Pathology 210 450-458. (Pubitemid 44830605)
24. Kaji H, Canaff L, Lebrun JJ, Goltzman D & Hendy GN 2001 Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type β signaling. PNAS 98 3837-3842. (Pubitemid 32249858)
25. Kim H, Lee JE, Cho EJ, Liu JO & Youn HD 2003 Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Research 63 6135-6139. (Pubitemid 37255151)
26. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G & Kallioniemi OP 1998 Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Medicine 4 844-847. (Pubitemid 28331029)
27. La P, Schnepp RW, Petersen CD, Silva AC & Hua X 2004 Tumor suppressor menin regulates expression of insulin-like growth factor binding protein 2. Endocrinology 145 3443-3450. (Pubitemid 38830017)
28. La P, Desmond A, Hou Z, Silva AC, Schnepp RW & Hua X 2006 Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression. Oncogene 25 3537-3546. (Pubitemid 43901675)
29. Larsson C, Skogseid B, Oberg K, Nakamura Y & Nordenskjold M 1988 Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332 85-87. (Pubitemid 18083554)
30. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G et al. 1997 Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Human Molecular Genetics 6 1177-1183. (Pubitemid 27308405)
31. Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Skarulis MC, James LA, Goldsmith PK, Saggar SK, Park SY et al. 1999 Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Progress in Hormone Research 54 397-438.
32. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D et al. 2005 Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. PNAS 102 749-754.
33. Missiaglia E, Dalai I, Barbi S, Beghelli S, Falconi M, della Peruta M, Piemonti L, Capurso G, Di Florio A, delle Fave G et al. 2010 Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. Journal of Clinical Oncology 28 245-255.
34. Moore PS, Missiaglia E, Antonello D, Zamo A, Zamboni G, Corleto V, Falconi M & Scarpa A 2001 Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. Genes, Chromosomes and Cancer 32 177-181.
35. Ohkura N, Kishi M, Tsukada T & Yamaguchi K 2001 Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23. Biochemical and Biophysical Research Communications 282 1206-1210.
36. Pannett AA & Thakker RV 1999 Multiple endocrine neoplasia type 1. Endocrine-Related Cancer 6 449-473.
37. Rigaud G, Missiaglia E, Moore PS, Zamboni G, Falconi M, Talamini G, Pesci A, Baron A, Lissandrini D, Rindi G et al. 2001 High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Research 61 285-292.
38. Schnepp RW, Mao H, Sykes SM, Zong WX, Silva A, La P & Hua X 2004 Menin induces apoptosis in murine embryonic fibroblasts. Journal of Biological Chemistry 279 10685-10691.
39. Shan L, Nakamura Y, Nakamura M, Yokoi T, Tsujimoto M, Arima R, Kameya T & Kakudo K 1998 Somatic mutations of multiple endocrine neoplasia type 1 gene in the sporadic endocrine tumors. Laboratory Investigation 78 471-475.
40. Speel EJ, Richter J, Moch H, Egenter C, Saremaslani P, Rutimann K, Zhao J, Barghorn A, Roth J, Heitz PU et al. 1999 Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. American Journal of Pathology 155 1787-1794.
41. Sukhodolets KE, Hickman AB, Agarwal SK, Sukhodolets MV, Obungu VH, Novotny EA, Crabtree JS, Chandrasekharappa SC, Collins FS, Spiegel AM et al. 2003 The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Molecular and Cellular Biology 23 493-509.
42. Yaguchi H, Ohkura N, Takahashi M, Nagamura Y, Kitabayashi I & Tsukada T 2004 Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. Molecular and Cellular Biology 24 6569-6580.
43. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W & Cleary ML 2004 Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Molecular and Cellular Biology 24 5639-5649.